Mobile Interventional Stroke Team Model Improves Early Outcomes in Large Vessel Occlusion Stroke

 

You don't know what you are doing do you? You have no clue how fast tPA needs to be delivered to get 100% recovery.  You are not even measuring 100% recovery you blithering idiots, you are measuring recanalization. 

Mobile Interventional Stroke Team Model Improves Early Outcomes in Large Vessel Occlusion Stroke

The NYC MIST Trial

Jacob R. Morey

,

Thomas J. Oxley

,

Daniel Wei

,

Christopher P. Kellner

,

Neha S. Dangayach

,

Laura Stein

,

Danny Hom

,

Danielle Wheelwright

,

Liorah Rubenstein

,

Maryna Skliut

,

Hazem Shoirah

, … See all authors

and on behalf of the Mount Sinai Stroke Investigators*

Originally published2 Nov 2020https://doi.org/10.1161/STROKEAHA.120.030248Stroke. 2020;51:3495–3503

• This article is commented on by the following:
• is related to

Abstract

Background and Purpose:

Triage of patients with emergent large vessel occlusion stroke to primary stroke centers followed by transfer to comprehensive stroke centers leads to increased time to endovascular therapy. A Mobile Interventional Stroke Team (MIST) provides an alternative model by transferring a MIST to a Thrombectomy Capable Stroke Center (TSC) to perform endovascular therapy. Our aim is to determine whether the MIST model is more time-efficient and leads to improved clinical outcomes compared with standard drip-and-ship (DS) and mothership models.

Methods:

This is a prospective observational cohort study with 3-month follow-up between June 2016 and December 2018 at a multicenter health system, consisting of one comprehensive stroke center, 4 TSCs, and several primary stroke centers. A total of 228 of 373 patients received endovascular therapy via 1 of 4 models: mothership with patient presentation to a comprehensive stroke center, DS with patient transfer from primary stroke center or TSC to comprehensive stroke center, MIST with patient presentation to TSC and MIST transfer, or a combination of DS with patient transfer from primary stroke center to TSC and MIST. The prespecified primary end point was initial door-to-recanalization time and secondary end points measured additional time intervals and clinical outcomes at discharge and 3 months.

Results:

MIST had a faster mean initial door-to-recanalization time than DS by 83 minutes (P<0.01). MIST and mothership had similar median door-to-recanalization times of 192 minutes and 179 minutes, respectively (P=0.83). A greater proportion had a complete recovery(How many?) (National Institutes of Health Stroke Scale of 0 or 1) at discharge in MIST compared with DS (37.9% versus 16.7%; P<0.01). MIST had 52.8% of patients with modified Rankin Scale of ≤2 at 3 months compared with 38.9% in DS (P=0.10).

Conclusions:

MIST led to significantly faster initial door-to-recanalization times compared with DS, which was comparable to mothership. This decrease in time has translated into improved short-term outcomes and a trend towards improved long-term outcomes.

Registration:

URL: https://www.clinicaltrials.gov. Unique identifier: NCT03048292.